Pharmacokinetics of N‐acetylprocainamide in patients profiled with a stable isotope method

[1]  Douglas A. Abraham Mathematical statistics , 2021, CSC '73.

[2]  A. Atkinson,et al.  D‐Xylose absorption and disposition in patients with moderately impaired renal function , 1987, Clinical pharmacology and therapeutics.

[3]  L L Huntsman,et al.  Noninvasive Doppler Determination of Cardiac Output in Man: Clinical Validation , 1983, Circulation.

[4]  A. Atkinson,et al.  Identification of desethyl procainamide in patients: a new metabolite of procainamide. , 1981, The Journal of pharmacology and experimental therapeutics.

[5]  D. Drayer,et al.  Aging and renal clearance of procainamide and acetylprocainamide , 1980, Clinical pharmacology and therapeutics.

[6]  A. Atkinson,et al.  Kinetics of N‐acetylprocainamide deacetylation , 1980, Clinical pharmacology and therapeutics.

[7]  Carl V. Manion,et al.  Absorption kinetics of procainamide in humans. , 1977, Journal of pharmaceutical sciences.

[8]  A. Atkinson,et al.  Absolute bioavailability in man of N‐acetylprocainamide determined by a novel stable isotope method , 1975, Clinical pharmacology and therapeutics.

[9]  F. Lewis,et al.  Evaluation of computer diagnosis of ectopic beats encountered in routine patient monitoring. , 1975, Computers in biology and medicine.

[10]  John G. Wagner,et al.  Fundamentals of Clinical Pharmacokinetics , 1975 .

[11]  G. Ertingshausen,et al.  Automated reaction-rate method for determination of serum creatinine with the CentrifiChem. , 1971, Clinical chemistry.

[12]  J. Koch-weser PHARMACOKINETICS OF PROCAINAMIDE IN MAN * , 1971 .

[13]  N. Shock,et al.  Blood and plasma volume in adult males. , 1962, Journal of applied physiology.

[14]  H. Black,et al.  Drug metabolism and pharmacokinetic studies in man utilising nitrogen-15- and deuterium-labelled drugs: the metabolic fate of cinoxacin and the metabolism and pharmacokinetics of propoxyphene , 1978 .